Human brain effects of DMT assessed via EEG-fMRI | ||
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | University of Sussex | |
| dc.conicet.organizacion | University of Oxford | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Universidad Adolfo Ibañez | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires | |
| dc.conicet.organizacion | McGill University. Montreal Neurological Institute and Hospital | |
| dc.conicet.organizacion | Université Fédérale Toulouse | |
| dc.conicet.organizacion | King's College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | Imperial College London | |
| dc.conicet.organizacion | University of California | |
| dc.contributor.author | Timmermann, Christopher | |
| dc.contributor.author | Roseman, Leor | |
| dc.contributor.author | Haridas, Sharad | |
| dc.contributor.author | Rosas, Fernando E. | |
| dc.contributor.author | Luan, Lisa | |
| dc.contributor.author | Kettner, Hannes | |
| dc.contributor.author | Martell, Jonny | |
| dc.contributor.author | Erritzoe, David | |
| dc.contributor.author | Tagliazucchi, Enzo Rodolfo | |
| dc.contributor.author | Pallavicini, Carla | |
| dc.contributor.author | Girn, Manesh | |
| dc.contributor.author | Alamia, Andrea | |
| dc.contributor.author | Leech, Robert | |
| dc.contributor.author | Nutt, David J. | |
| dc.contributor.author | Carhart-Harris, Robin L. | |
| dc.date.issued | 2023-03 | |
| dc.description.abstract | Psychedelics have attracted medical interest, but their effects on human brain function are incompletely understood. In a comprehensive, within-subjects, placebo-controlled design, we acquired multimodal neuroimaging [i.e., EEG-fMRI (electroencephalography-functional MRI)] data to assess the effects of intravenous (IV) N,N-Dimethyltryptamine (DMT) on brain function in 20 healthy volunteers. Simultaneous EEG-fMRI was acquired prior to, during, and after a bolus IV administration of 20 mg DMT, and, separately, placebo. At dosages consistent with the present study, DMT, a serotonin 2A receptor (5-HT2AR) agonist, induces a deeply immersive and radically altered state of consciousness. DMT is thus a useful research tool for probing the neural correlates of conscious experience. Here, fMRI results revealed robust increases in global functional connectivity (GFC), network disintegration and desegregation, and a compression of the principal cortical gradient under DMT. GFC × subjective intensity maps correlated with independent positron emission tomography (PET)-derived 5-HT2AR maps, and both overlapped with meta-analytical data implying human-specific psychological functions. Changes in major EEG-measured neurophysiological properties correlated with specific changes in various fMRI metrics, enriching our understanding of the neural basis of DMT's effects. The present findings advance on previous work by confirming a predominant action of DMT - and likely other 5-HT2AR agonist psychedelics - on the brain's transmodal association pole, i.e., the neurodevelopmentally and evolutionarily recent cortex that is associated with species-specific psychological advancements, and high expression of 5-HT2A receptors. | es |
| dc.description.fil | Fil: Timmermann, Christopher. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Roseman, Leor. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Haridas, Sharad. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Rosas, Fernando E.. University of Sussex; Reino Unido. University of Oxford; Reino Unido. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Luan, Lisa. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Kettner, Hannes. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Martell, Jonny. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Erritzoe, David. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Tagliazucchi, Enzo Rodolfo. Universidad Adolfo Ibañez; Chile. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires; Argentina | |
| dc.description.fil | Fil: Pallavicini, Carla. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires; Argentina | |
| dc.description.fil | Fil: Girn, Manesh. McGill University. Montreal Neurological Institute and Hospital; Canadá | |
| dc.description.fil | Fil: Alamia, Andrea. Université Fédérale Toulouse; Francia | |
| dc.description.fil | Fil: Leech, Robert. King's College London; Reino Unido | |
| dc.description.fil | Fil: Nutt, David J.. Imperial College London; Reino Unido | |
| dc.description.fil | Fil: Carhart-Harris, Robin L.. Imperial College London; Reino Unido. University of California; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Timmermann, Christopher; Roseman, Leor; Haridas, Sharad; Rosas, Fernando E.; Luan, Lisa; et al.; Human brain effects of DMT assessed via EEG-fMRI; National Academy of Sciences; Proceedings of the National Academy of Sciences of The United States of America; 120; 13; 3-2023; 1-12 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0027-8424 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/228617 | |
| dc.journal.ciudad | Washington D.C | es |
| dc.journal.number | 13 | es |
| dc.journal.pagination | 1-12 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Proceedings of the National Academy of Sciences of The United States of America | es |
| dc.journal.volume | 120 | es |
| dc.language.iso | eng | es |
| dc.publisher | National Academy of Sciences | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1073/pnas.2218949120 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.pnas.org/doi/10.1073/pnas.2218949120 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | AYAHUASCA | es |
| dc.subject | CONSCIOUSNESS | es |
| dc.subject | DIMETHYLTRYPTAMINE | es |
| dc.subject | PSYCHEDELICS | es |
| dc.subject | SEROTONIN | es |
| dc.subject.classification | Otras Ciencias Físicas | es |
| dc.subject.classification | Ciencias Físicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Human brain effects of DMT assessed via EEG-fMRI | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.27eb4b14-3c92-4af8-b3f3-7bf0778fdc20_B.pdf
- Tamaño:
- 3.31 MB
- Formato:
- Adobe Portable Document Format